Turner Investments’s Aratana Therapeutics, Inc. PETX Stock Holding History

Turner Investments’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-88,000	Closed	-$632K	–	302
2016 Q4	$632K	Sell	88,000 -120,660	-58%	-$976K	0.26%	133
2016 Q3	$1.95M	Sell	208,660 -153,330	-42%	-$1.27M	0.65%	56
2016 Q2	$2.29M	Sell	361,990 -147,510	-29%	-$949K	0.72%	50
2016 Q1	$2.81M	Buy	+509,500	New	+$1.92M	0.76%	45

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Turner Investments's PETX Position: Q1 2017 in Review

Turner Investments sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2017, closing a stake of 88,000 shares — an estimated $632K sold.

Turner Investments first reported a position in PETX in Q1 2016 and held it in 4 quarters. The position peaked at $2.81M in Q1 2016. 98 funds tracked by Wall St. Rank hold PETX as of Q1 2017.

Turner Investments reported no remaining Aratana Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Turner Investments sold 88,000 Aratana Therapeutics, Inc. shares in Q1 2017, an estimated $632K.
Turner Investments first reported a position in Aratana Therapeutics, Inc. in Q1 2016 and held it in 4 quarters.
Turner Investments's Aratana Therapeutics, Inc. position peaked at $2.81M in Q1 2016.
98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.